Overview

Drug Interaction Study of Safinamide and a BCRP Substrate, Diclofenac, Concomitantly Administered to Healthy Volunteers

Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
To evaluate if a single dose of safinamide 200 mg has an effect on the pharmacokinetics of diclofenamic acid, concomitantly administered as a single 50 mg diclofenac sodium dose, with respect to 50 mg diclofenac sodium administered alone.
Phase:
Phase 1
Details
Lead Sponsor:
Zambon SpA
Collaborator:
Cross Research S.A.
Treatments:
Diclofenac